2012
DOI: 10.1007/s12640-012-9355-2
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury

Abstract: The spinal cord is composed of distinct neuronal groups with well-defined anatomic connections. In some transgenic models of Alzheimer’s disease (AD) amyloid plaques develop in this structure, although the underlying cellular mechanism remains elusive. We attempted to explore the origin, evolution and modulation of spinal β-amyloid (Aβ) deposition using transgenic mice harboring five familiar AD-related mutations (5XFAD) as an experiential model. Dystrophic neuritic elements with enhanced β-secretase-1 (BACE1)… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
13
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 15 publications
(15 citation statements)
references
References 61 publications
2
13
0
Order By: Relevance
“…In human and transgenic animal brains with amyloid plaque pathology, BACE1 immunoreactivity is increased but preferentially localized to swollen and sprouting axonal terminals or axonal dystrophic neurites [33]–[35] [42]. In the present study, BACE1 labeling in both cerebral hemispheres in the PBS injected brains and the contralateral cerebrum in the LPS-injected animals exhibited the aforementioned normal distribution pattern (Figure 3(A) and Figure 3(B)).…”
Section: Resultssupporting
confidence: 60%
See 1 more Smart Citation
“…In human and transgenic animal brains with amyloid plaque pathology, BACE1 immunoreactivity is increased but preferentially localized to swollen and sprouting axonal terminals or axonal dystrophic neurites [33]–[35] [42]. In the present study, BACE1 labeling in both cerebral hemispheres in the PBS injected brains and the contralateral cerebrum in the LPS-injected animals exhibited the aforementioned normal distribution pattern (Figure 3(A) and Figure 3(B)).…”
Section: Resultssupporting
confidence: 60%
“…Besides synaptic degeneration, axonal elements including presynaptic terminals undergo aberrant sprouting and dystrophic expansion [30]–[32]. Recent data from transgenic AD models, nonhuman primates and human subjects show that upregulation of the amyloidogenic proteins, especially the rate-limiting enzyme β -secretase-1 (BACE1), appears to be an molecular cascade tightly associated with axonal sprouting and dystrophy, suggestive of a driving role for amyloidogenic axonal pathology in plaque formation [33]–[35]. …”
Section: Introductionmentioning
confidence: 99%
“…BACE1 elevation appears to occur in the brain from a fairly early age among several plaque-forming transgenic AD models examined so far, including Tg2576, 2XFAD, 5XFAD, and 3xTgAD [10,11,35-37,39,66,67]. Importantly, the onset and evolution of typical neuritic plaques in the brain and spinal cord correlate with a progressive axon terminal pathology associated with BACE1 overexpression.…”
Section: Introductionmentioning
confidence: 99%
“…Besides BACE1, the abnormal axonal elements can also be co-labeled by antibodies against the transgenic AβPP, Aβ monomers or aggregates, and some specific neuronal phenotype markers. Extracellular Aβ deposits are absent from the small and isolated dystrophic axon terminals, but emerge and accumulate with the growth/expansion of the dystrophic neurites, especially as these neurites become rosette-like clusters [36,37,55,59, 62, 66-70] (Fig. 2A-D).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation